ENTRY       D11390            Mixture   Drug
NAME        Daunorubicin and cytarabine;
            Vyxeos (TN)
COMPONENT   Daunorubicin [DR:D07776], Cytarabine [DR:D00168]
REMARK      ATC code: L01XY01
EFFICACY    Antineoplastic
  DISEASE   Acute myeloid leukemia [DS:H00003]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XY Combinations of antineoplastic agents
                 L01XY01 Cytarabine and daunorubicin
                  D11390  Daunorubicin and cytarabine
            USP drug classification [BR:br08302]
             Antineoplastics
              Antineoplastics, Other
               Daunorubicin/ Cytarabine
                D11390  Daunorubicin and cytarabine
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11390
DBLINKS     PubChem: 384585368
///
